Selinisol Tablets Directions and Dosage Instructions

Selinexor is an oral selective nuclear export protein XPO1 inhibitor, mainly used to treat relapsed or refractory multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL). In recent years, the drug's indications have been expanded to include myelofibrosis and other hematological malignancies.

In the treatment of multiple myeloma, selinesol is often given in combination with dexamethasone. The standard recommended dose is 80mg twice a week (e.g. every Monday and Wednesday). In diffuse large B-cell lymphoma, this drug is usually used as a single agent, with the recommended dose being 60 mg twice weekly. In addition, in clinical studies in other indications such as myelofibrosis, the dose of selinesol may be adjusted based on patient tolerance, and the starting dose may be 40-60 mg once or twice a week to reduce adverse reactions.

When taking selinesol, it is recommended that patients drink enough water and maintain adequate nutritional intake before and after taking the drug to reduce gastrointestinal discomfort such as nausea and vomiting. Since this drug may cause dehydration and electrolyte imbalance, it is recommended that patients supplement sufficient fluids during use and regularly monitor biochemical indicators such as blood routine and liver and kidney function.

Common adverse reactions include decreased appetite, nausea, vomiting, fatigue, thrombocytopenia, and anemia. In order to reduce side effects, doctors may adjust the dosage or use antiemetic drugs, supportive treatment measures, etc. in combination. Additionally, selinesol may interact with other medications, so inform your doctor of all medications you are taking, including prescription drugs, over-the-counter drugs, and dietary supplements before use.

In general, selinesol is an effective anti-tumor drug, but it needs to be used strictly in accordance with the doctor's instructions and adverse reactions must be closely monitored. Patients should fully communicate with their doctors before treatment to ensure reasonable dosage adjustment and optimal treatment plan.

Reference materials:https://www.selincro.com/